Osteomyelitis is an inflammatory condition of bone secondary to infection, classified as acute (days to weeks), subacute (2 weeks to 3 months), or chronic (months to years), and by mechanism as hematogenous or nonhematogenous (contiguous/direct inoculation). ** [1]Methicillin-sensitive Staphylococcus aureus* is the most common pathogen across all types. [1]
The following figure illustrates the most common causative organisms by anatomic site:
1. History
- Pain characterization: Location, onset (acute vs insidious), severity, radiation, aggravating/relieving factors; pain out of proportion to soft tissue findings raises suspicion [3]
- Timing and progression: Acute onset over days (acute osteomyelitis) vs months of smoldering symptoms (chronic); nonhealing wound or ulcer present >6 weeks [1][4]
- Constitutional symptoms: Fever, chills, malaise, lethargy, irritability — more common in acute disease; often absent in chronic osteomyelitis and immunocompromised patients [1]
- Mechanism: Recent trauma, surgery, open fracture, IV drug use, recent bacteremia, indwelling catheter, diabetic foot ulcer, decubitus ulcer [1][5]
- Important negatives: Absence of fever does not rule out osteomyelitis, especially in chronic disease or immunosuppression [1]
2. Alarm Features
- Sepsis/SIRS signs: Fever >38°C or <36°C, HR >90, RR >20, WBC >12,000 or <4,000 [6]
- Neurologic deficits (vertebral osteomyelitis): New weakness, bowel/bladder dysfunction suggesting epidural abscess or cord compression [1]
- Rapidly progressive soft tissue infection, crepitus, or gas gangrene suggesting necrotizing fasciitis [7]
- Exposed bone through a wound [1]
- "Sausage toe" in diabetic patients — highly suggestive of underlying osteomyelitis [6]
- Hemodynamic instability requiring immediate empiric antibiotics before cultures [1][8]
3. Medications
Relevant contributors
- Prior antibiotic use may reduce culture yield — delay empiric therapy until cultures obtained when clinically stable [1][8]
- Immunosuppressants (steroids, biologics, chemotherapy) increase risk
Common empiric regimens (adults): [1][8-9]
Key medication pearls
- Rifampin improves cure rates with prosthetic joint/implant infections; wait until bacteremia clears before initiating [1][9]
- Parenteral-to-oral switch is supported by evidence (OVIVA trial); oral antibiotics with good bioavailability (fluoroquinolones, linezolid, TMP-SMX, clindamycin) are reasonable [1][9]
- Duration: Typically 4–6 weeks; 6 weeks noninferior to 12 weeks for vertebral osteomyelitis; shorter courses (3–4 weeks) may suffice after adequate debridement [8-9]
- β-lactams should generally not be given orally for osteomyelitis due to low bioavailability, though recent data support first-generation cephalosporins (cephalexin, cefadroxil) in select cases [10-11]
Contraindicated/cautions
- Avoid fluoroquinolone monotherapy against S. aureus (rapid resistance emergence) [11]
- Linezolid: monitor for myelosuppression, serotonin syndrome, peripheral neuropathy with prolonged use
4. Diet
- No specific dietary triggers
- Ensure adequate protein and caloric intake to support wound healing, especially in diabetic and malnourished patients
- Glycemic control is critical in diabetic foot osteomyelitis — poor glucose control impairs immune function and wound healing [1][7]
- Adequate hydration, particularly with nephrotoxic antibiotics (vancomycin, aminoglycosides)
5. Review of Systems
- MSK: Focal bone pain, joint swelling, decreased ROM, limp (pediatrics), inability to bear weight [3][12]
- Constitutional: Fever, night sweats, weight loss, fatigue
- Neuro (vertebral): Back/neck pain, radiculopathy, weakness, bowel/bladder changes [1]
- Vascular: Claudication, rest pain, nonhealing wounds (peripheral vascular disease)
- Skin: Draining sinus tracts, chronic ulcers, erythema, warmth
- GU: Urinary symptoms (potential source for hematogenous vertebral osteomyelitis) [5]
6. Collateral History and Family History
- IV drug use history — associated with Pseudomonas, Candida, vertebral osteomyelitis [1][5]
- Recent hospitalizations, surgeries, or procedures — risk for healthcare-associated organisms including MRSA [1]
- Sickle cell disease (family history) — predisposes to Salmonella osteomyelitis [1]
- Immigration/travel history — tuberculosis, brucellosis in endemic areas [5]
- Social context: Homelessness, poor wound care access, nonadherence to diabetic management
7. Risk Factors
- Diabetes mellitus (especially with neuropathy and foot ulcers) — 20% of diabetic foot ulcers develop osteomyelitis [4][13]
- Peripheral vascular disease [1]
- IV drug use [1]
- Immunocompromise (HIV, transplant, chemotherapy, chronic steroids) [1]
- Sickle cell disease [1]
- Orthopedic hardware/prosthetic joints [1]
- Recent surgery or trauma/open fractures [5]
- Chronic wounds/decubitus ulcers [1]
- Smoking — increases risk from diabetic foot infections and impairs fracture healing [1]
- Age extremes: Neonates (hematogenous), prepubertal children (metaphyseal long bones), elderly [1]
8. Differential Diagnosis
- Soft tissue infection (cellulitis, abscess) — most common mimic; no bony changes on imaging [1]
- Gout/pseudogout — acute monoarticular, crystal-positive aspirate [1]
- Charcot neuroarthropathy — diabetic patients; can coexist with osteomyelitis; MRI helps differentiate [1]
- Fracture (stress or pathologic) [1]
- Malignancy: Ewing sarcoma, osteosarcoma, metastases, Langerhans cell histiocytosis — especially in children with bone pain and constitutional symptoms [3]
- Bursitis [1]
- Avascular necrosis/osteonecrosis [1]
- Sickle cell vasoocclusive crisis [1]
- SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, osteitis) [1]
- Septic arthritis — may coexist; joint effusion, restricted ROM [3]
- Leukemia — bone pain in children [3]
9. Past Medical History
- Prior episodes of osteomyelitis (chronic/recurrent disease)
- Diabetes mellitus and HbA1c control
- Peripheral vascular disease, prior amputations
- Sickle cell disease
- Prior orthopedic surgeries, hardware placement
- Immunosuppressive conditions or medications
- History of MRSA colonization or infection
- Recent bacteremia or endocarditis
10. Physical Exam
Vital signs: Fever (may be absent in chronic disease), tachycardia, hypotension (if septic)
Focused exam
- Inspection: Erythema, edema, warmth, draining sinus tracts (pathognomonic for chronic osteomyelitis), exposed bone [1]
- Palpation: Point tenderness over bone, fluctuance suggesting abscess
- ROM: Decreased range of motion of adjacent joints [1]
- Probe-to-bone test (diabetic foot): Sterile blunt metal probe inserted into wound — positive if hard, gritty bone is palpated; sensitivity 87%, specificity 83%; high positive predictive value in high-risk patients, high negative predictive value in low-risk patients [6][14-15]
- Neurovascular exam: Peripheral pulses, sensation (neuropathy assessment), motor function
- Spine: Midline tenderness, paraspinal muscle spasm (vertebral osteomyelitis); neurologic exam for cord compression [1]
- Pediatrics: Limp, refusal to bear weight, pseudoparalysis in neonates [3][12]
11. Lab Studies
Initial workup: [1][5]
- CBC: Leukocytosis in acute disease; may be normal in chronic osteomyelitis; thrombocytosis may predict osteomyelitis in chronic leg ulcers [1]
- ESR: Often elevated; ESR >70 mm/h has LR of 11 for diabetic foot osteomyelitis; poor diagnostic accuracy as a standalone test [10][14]
- CRP: More useful for monitoring treatment response than ESR; declining CRP suggests favorable response; CRP >10.3 mg/dL in children correlates with subperiosteal abscess [12][16]
- Blood cultures: 2 sets aerobic and anaerobic — positive blood cultures with radiographic evidence may obviate bone biopsy [1][5]
- Procalcitonin: Poor diagnostic accuracy for osteomyelitis; not recommended as a primary diagnostic tool [10]
Combination markers: ESR >60 mm/h + CRP ≥8 mg/dL has high positive predictive value for diabetic foot osteomyelitis; positive probe-to-bone + ESR >43 mm/h is highly predictive [15]
Special situations
- Brucella serology in endemic areas [5]
- IGRA/PPD if tuberculosis risk [5]
- Fungal blood cultures if immunocompromised [5]
- Negative MRSA nasal swab has >90% NPV for excluding MRSA in diabetic foot osteomyelitis in low-prevalence settings [10]
Gold standard: Bone biopsy with culture and histopathology — definitive diagnosis [1][5]
12. Imaging
First-line: Plain radiographs [1]
- Low sensitivity early (50–75% bone matrix must be destroyed before lytic changes visible)
- Findings: Soft tissue swelling, osteopenia, cortical loss, periosteal reaction, bony destruction
- Normal radiograph does NOT rule out osteomyelitis
- Useful to exclude fracture, tumor; repeat in 2–3 weeks if initially normal [15]
Gold standard: MRI with and without contrast [1]
- Sensitivity 93%, specificity 75% for osteomyelitis [14]
- Best for identifying bone marrow edema, abscess, extent of infection, epidural involvement
- Contrast helps distinguish abscess from phlegmon in chronic disease [1]
When MRI is contraindicated: [1]
- Tagged leukocyte scan (Indium-111): highly accurate for vertebral osteomyelitis (LR+ 30, LR− 0.1) [10]
- Gallium-67 scintigraphy (LR+ 7.9, LR− 0.09 for vertebral osteomyelitis) [10]
- PET/CT or SPECT
- CT scan — useful for surgical planning, guiding biopsy, detecting sequestra
When imaging may be unnecessary: Positive probe-to-bone test + plain radiograph findings in hospitalized diabetic patients with high pretest probability (combined LR 14) [14]
13. Special Tests
- Probe-to-bone test: Sensitivity 87%, specificity 83% for diabetic foot osteomyelitis [6]
- Cierny-Mader staging system: Classifies by anatomic type (stages 1–4) and host physiology (A, B, C) to guide surgical decision-making [1]
- Bone biopsy: Imaging-guided or open; submit for aerobic/anaerobic culture, Gram stain, histopathology; swabs are NOT recommended [5]
- PCR/molecular diagnostics: May help when cultures are negative or post-antibiotic; not first-line [1][5]
- Percutaneous endoscopic debridement and drainage (PEDD): More accurate than CT-guided needle biopsy for spinal osteomyelitis [10]
- Disk space/paravertebral soft tissue biopsies have higher yield (65%) than vertebral bone biopsies (46%) [10]
14. ECG
- Not routinely indicated for osteomyelitis itself
- Obtain ECG if:
- Sepsis or hemodynamic instability (evaluate for myocardial dysfunction)
- Suspected endocarditis as source of hematogenous osteomyelitis (especially S. aureus bacteremia)
- Monitoring for QTc prolongation with fluoroquinolones or other QT-prolonging antibiotics
15. Assessment
Severity stratification
- Acute osteomyelitis: Rapid onset, fever, localized pain/swelling; no necrotic bone; responds well to antibiotics if treated early [1]
- Chronic osteomyelitis: Months to years; necrotic bone (sequestra), sinus tracts; typically requires surgical debridement [1][17]
- Vertebral osteomyelitis: Most common hematogenous form in adults; failure rates 10–30% [8]
- Diabetic foot osteomyelitis: Often polymicrobial; high amputation risk; multidisciplinary approach essential [7][13]
Typical vs atypical presentations
- Adults may lack constitutional symptoms, especially if immunocompromised [1]
- Children: Pelvic osteomyelitis may present with non-localizing pain, limp, or groin pain causing diagnostic delay [3]
- MRSA osteomyelitis: Higher fevers, more elevated inflammatory markers, greater risk of DVT and septic pulmonary emboli [12]
Complications: Pathologic fracture, septic arthritis, epidural abscess, chronic osteomyelitis, growth plate damage (pediatrics), amputation, sepsis [3][12]
16. Treatment Plan
Initial stabilization
- IV access, fluid resuscitation if septic
- Pain management
- Immobilization of affected extremity
Antibiotic therapy: [1][9][9]
- Delay antibiotics until cultures obtained (blood cultures ± bone biopsy) unless septic, neurologic compromise, or epidural extension [1]
- Empiric regimen: Ceftriaxone ± vancomycin (add vancomycin if MRSA risk factors) [8-9]
- Tailor to culture and sensitivity results
- Duration: 4–6 weeks standard; 6 weeks noninferior to 12 weeks for vertebral osteomyelitis [8]
- IV-to-oral switch supported when clinical improvement and CRP trending down [1][8]
The WikiGuidelines empirical antibiotic table provides a comprehensive framework:
Surgical indications: [1][17]
- Necrotic bone (sequestra) requiring debridement
- Underlying orthopedic hardware infection
- Abscess requiring drainage (≥2 cm in pediatrics) [3]
- Failure of medical therapy
- Epidural abscess with neurologic compromise
- Exposed bone, compartment syndrome
- Chronic osteomyelitis (generally cannot be eradicated without surgery) [17]
Adjunctive therapies
- Antibiotic-loaded collagen sponges or PMMA beads for dead space management [1]
- Hyperbaric oxygen therapy — may benefit chronic osteomyelitis [1]
- Wound care and offloading for diabetic foot osteomyelitis
17. Disposition
Admission criteria
- Sepsis or hemodynamic instability
- Need for IV antibiotics (initial stabilization)
- Vertebral osteomyelitis with epidural abscess or neurologic deficits
- Surgical debridement required
- Severe diabetic foot infection (IWGDF/IDSA grade 4) [6]
- Unreliable patient or inability to ensure outpatient follow-up
- Pediatric patients with high CRP, bacteremia, or suspected complicated disease [16]
Observation/outpatient considerations
- Stable patients with suspected osteomyelitis may be started on workup (labs, imaging, blood cultures) and discharged with close ID/orthopedic follow-up if not acutely ill
- OPAT (outpatient parenteral antibiotic therapy) is appropriate after initial stabilization for patients requiring prolonged IV therapy
Specialist consultation triggers
- Infectious disease: All cases — for antibiotic selection, duration, and monitoring
- Orthopedic surgery: Hardware-associated infection, need for debridement, chronic osteomyelitis, pathologic fracture
- Vascular surgery: Diabetic foot osteomyelitis with peripheral arterial disease
- Neurosurgery/spine surgery: Vertebral osteomyelitis with epidural abscess or instability
18. Follow Up / Return Precautions
Follow-up timing
- ID follow-up within 1–2 weeks of discharge
- Orthopedic follow-up if surgical intervention performed
- Serial CRP monitoring to assess treatment response (more useful than ESR for trending) [12]
- Repeat imaging only if clinical concern for treatment failure or complications
Return precautions — instruct patients to return immediately for:
- New or worsening fever, chills, rigors
- Increasing pain, swelling, or redness at the affected site
- New drainage or sinus tract formation
- Neurologic symptoms (weakness, numbness, bowel/bladder changes) — especially vertebral osteomyelitis
- Signs of antibiotic adverse effects (rash, GI symptoms, vision changes with linezolid)
Patient counseling
- Emphasize full antibiotic course completion — premature discontinuation risks chronic osteomyelitis and relapse
- Diabetic patients: strict glycemic control, daily foot inspections, appropriate footwear [1][7]
- Smoking cessation — smoking impairs healing and increases infection risk [1]
- Activity modification and weight-bearing restrictions as directed by orthopedics
Expected recovery
- Acute uncomplicated osteomyelitis: good prognosis with appropriate antibiotics; cure rates >90% in children treated early [12]
- Chronic osteomyelitis: relapse rates 10–30%; may require multiple surgeries [8][17]
- Diabetic foot osteomyelitis: significant amputation risk; multidisciplinary care reduces morbidity [13]
References
1. Osteomyelitis: Diagnosis and Treatment. — Bury DC, Rogers TS, Dickman MM. American Family Physician. 2021.
2. Osteomyelitis. — Ian T. Ferguson, Christopher R. Carpenter Evidence‐Based Emergency Care. 2023.
3. Clinical Practice Guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics. — Woods CR, Bradley JS, Chatterjee A, et al. Journal of the Pediatric Infectious Diseases Society. 2021.
4. ACR Appropriateness Criteria® Suspected Osteomyelitis of the Foot in Patients With Diabetes Mellitus: 2025 Update. — Expert Panel on Musculoskeletal Imaging, Baker JC, Northrup BE, et al. Journal of the American College of Radiology : JACR. 2025.
5. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.
6. IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-Related Foot Infections (IWGDF/IDSA 2023). — Senneville É, Albalawi Z, van Asten SA, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2023.
7. Diabetes-Related Foot Infections: Diagnosis and Treatment. — Matheson EM, Bragg SW, Blackwelder RS. American Family Physician. 2021.
8. 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. — Berbari EF, Kanj SS, Kowalski TJ, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2015.
9. Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults: A WikiGuidelines Group Consensus Statement. — Spellberg B, Aggrey G, Brennan MB, et al. JAMA Network Open. 2022.
10. 2025 Update to WikiGuidelines for the Management of Pyogenic Osteomyelitis in Adults. — Spellberg B, Ghanem B, Russell CD, et al. The American Journal of Medicine. 2025.
11. Vertebral Osteomyelitis. — Zimmerli W. The New England Journal of Medicine. 2010.
12. Acute Osteomyelitis in Children. — Peltola H, Pääkkönen M. The New England Journal of Medicine. 2014.
13. A Comprehensive Review of the Pathogenesis, Diagnosis, and Management of Diabetic Foot Infections. — Mponponsuo K, Sibbald RG, Somayaji R. Advances in Skin & Wound Care. 2021.
14. Diabetic Foot Ulcers: A Review. — Armstrong DG, Tan TW, Boulton AJM, Bus SA. The Journal of the American Medical Association. 2023.
15. Diagnosis and Treatment of Diabetes-Related Foot Infections: Guidelines From the IWGDF/IDSA. — Arnold MJ. American Family Physician. 2025.
16. Clinical Characteristics of Acute Hematogenous Osteomyelitis With and Without Subperiosteal Abscesses in the Acute Care Setting. — Hartman NR, Gerard JM, Puryear A, Sethi A, Flood RG. Pediatric Emergency Care. 2022.
17. Osteomyelitis. — Lew DP, Waldvogel FA. Lancet. 2004.